Avadel Pharmaceuticals
AVDL
#4809
Rank
C$3.01 B
Marketcap
C$30.73
Share price
0.00%
Change (1 day)
186.99%
Change (1 year)

Earnings for Avadel Pharmaceuticals (AVDL)

Earnings in 2025 (TTM): -C$5.18 Million

According to Avadel Pharmaceuticals 's latest financial reports the company's current earnings are C$0.24 Billion. In 2024 the company made an earning of -C$69.7 Million, an increase over its 2023 earnings that were of -C$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Avadel Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$5.18 Million-92.57%
2024 -C$69.7 Million-69.47%
2023 -C$0.23 Billion44.27%
2022 -C$0.16 Billion19.64%
2021 -C$0.14 Billion1732.84%
2020 -C$7.22 Million-86.83%
2019 -C$54.79 Million-65.92%
2018 -C$0.17 Billion-222.16%
2017 C$0.13 B-1053.49%
2016 -C$13.8 Million-112.59%
2015 C$0.10 B-185.94%
2014 -C$0.13 Billion66.04%
2013 -C$76.82 Million582.16%
2012 -C$11.27 Million-7.6%
2011 -C$12.19 Million-2.1%
2010 -C$12.45 Million32.52%
2009 -C$9.4 Million-64.36%
2008 -C$26.36 Million-52.93%
2007 -C$56 Million5.66%
2006 -C$53 Million17.86%
2005 -C$44.97 Million-375.09%
2004 C$16.34 M-406.44%
2003 -C$5.34 Million-145.2%
2002 C$11.79 M-363.36%
2001 -C$4.49 Million-80.62%
2000 -C$23.13 Million132.68%
1999 -C$9.94 Million-50.34%
1998 -C$20.01 Million54.85%
1997 -C$12.93 Million-28.35%
1996 -C$18.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.23 Billion 4,798.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$25.79 Million 457.62%๐Ÿ‡บ๐Ÿ‡ธ USA